Abstract 1234P
Background
Recently, the field of digital pathology has seen an increase in research utilizing deep learning techniques. This allows for predictions such as cancer diagnosis, prognosis, and treatment response, which previously required additional analysis, such as genetic analysis that was both time-consuming and costly, to be made based on pathological imaging. However, digital pathology images often contain noise, such as inconsistent staining and inconsistent annotations. To address this issue, image preprocessing is essential in deep learning analysis of digital pathology images, and various preprocessing techniques have been proposed to address issues such as bias, overfitting, and robust deep learning model development. However, automated preprocessing methods for digital pathology images have not yet been fully developed.
Methods
To address this, we have developed a user-friendly tool for image preprocessing analysis called HistoMate.
Results
HistoMate provides GUI-based image segmentation, image tiling, color normalization, and deep learning-based data augmentation to automate the preprocessing process. It also provides functionality to evaluate image quality and select appropriate patches.
Conclusions
In conclusion, HistoMate provides an automated preprocessing tool for pathological image-based research, accelerating digital pathology-based research.
Clinical trial identification
Editorial acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIT) (grant no. NRF-2021R1C1C1013706), and research fund by Seoul National University Bundang Hospital (grant no. 14-2018-0013).
Legal entity responsible for the study
The authors.
Funding
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIT) (grant no. NRF-2021R1C1C1013706), and research fund by Seoul National University Bundang Hospital (grant no. 14-2018-0013).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1229P - Selective phenotypic and genotypic evaluation of circulating glial cells for improved diagnosis of glial malignancies
Presenter: Sewanti Limaye
Session: Poster session 14
1230P - hPG80 (circulating progastrin) is a new blood-based biomarker for diagnosis of early-stage non-small cell lung cancers
Presenter: Paul Hofman
Session: Poster session 14
1231P - Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer
Presenter: Yeji Jung
Session: Poster session 14
1232P - Analytic analysis of PanSeer7, a targeted bisulfite sequencing assay for blood-based multi-cancer detection for cancer early detection and tissue-of-origin identification
Presenter: Xinrong Yang
Session: Poster session 14
1233P - Accurate prediction of gastrointestinal cancer tissue of origin using comprehensive plasma cell-free DNA fragmentomics features
Presenter: Xinrong Yang
Session: Poster session 14
1235P - Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway
Presenter: Aaslaug Helland
Session: Poster session 14
1236P - Feasibility of online symptom monitoring to detect lung cancer relapse in Poland
Presenter: Ewa Pawlowska
Session: Poster session 14
1237P - Design and validation of a custom next-generation sequencing panel in melanoma, glioma and gastrointestinal stromal tumor
Presenter: Xiaoyan Zhou
Session: Poster session 14
1238P - Detecting driver mutations by AmoyDx 11-gene PCR with high concordance with next-generation sequencing in Chinese non-small cell lung cancer patients
Presenter: Dongmei Lin
Session: Poster session 14
1239P - NHS-Galleri trial enrolment approaches and participant sociodemographic diversity
Presenter: Charles Swanton
Session: Poster session 14